Medgenics Inc. (DI) (MEDU)

All online trades £12.50 plus an annual Management Fee of £35 & VAT with Selftrade. Apply

355.00p
   
  • Change Today:
      10.00p
  • 52 Week High: 380.00
  • 52 Week Low: 165.00
  • Currency: UK Pounds
  • Shares Issued: 9.77m
  • Volume: 100
  • Market Cap: £34.69m

Latest ShareCast News

Losses trimmed at Medgenics

Date: Monday 16 Aug 2010

Tissue protein therapy technology firm Medgenics, best known for its Biopump technology, saw sharply reduced interim losses, primarily as a result of a collaboration with a major pharmaceutical firm.

MEDU ShareCast News

Early test results please Medgenics 22-Jun-2010 ShareCast
Small caps round-up: Independent Resources, Inte... 09-Jun-2010 ShareCast

MEDU Regulatory News

FDA Clearance for Phase IIb Trial of EPODURE 17-May-2012 15:00 RNS
1st Quarter Results 14-May-2012 18:09 RNS
Medgenics Awarded $2.2 Million Grant 09-May-2012 15:00 RNS
Medgenics Comments on Market Trading Activity 27-Apr-2012 07:00 RNS
Medgenics files for U.S. Orphan Drug Designation 23-Apr-2012 15:00 RNS

MEDU Newspaper Links

Medgenics granted key patent for Biopump system 24-Dec-2008 The Scotsman

MEDU Tips & Analysis

No recent information was found.

MEDU News Wires

No recent information was found.

Other MEDU News

No recent information was found.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

MEDU Market Data

Currency UK Pounds
Share Price 355.00p
Change Today 10.00p
% Change 2.90 %
52 Week High 380.00
52 Week Low 165.00
Volume 100
Shares Issued 9.77m
Market Cap £34.69m

MEDU Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value Not Available
Price Trend Not Available
Income Not Available
Growth Not Available

MEDU Dividends

No dividends found

Trades for 28-May-2012

Time Volume / Share Price
08:01 100 @ 370.00p

MEDU Key Personnel

CEO Andrew L Pearlman

Top of Page